We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer.
- Authors
Campos, Susana; Hamid, Oday; Seiden, Michael V; Oza, Amit; Plante, Marie; Potkul, Ronald K; Lenehan, Peter F; Kaldjian, Eric P; Varterasian, Mary L; Jordan, Cheryl; Charbonneau, Claudie; Hirte, Hal
- Abstract
To evaluate the antitumor activity and toxicity of two doses of CI-1033 in patients with platinum-refractory or recurrent ovarian cancer, and to determine baseline expression of epidermal growth factor receptor in tumor cells.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 24, p5597
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.08.091